{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:08:33Z","timestamp":1787972913634,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031376","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clim.2025.110610","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:34:35Z","timestamp":1761028475000},"page":"110610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate"],"prefix":"10.1016","volume":"282","author":[{"given":"Pauline","family":"Brevet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gillibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9na","family":"Le Goar\u00e9guer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lattard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Drouot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Varin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Golinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Candon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lequerr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fr\u00e9ret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.clim.2025.110610_bb0005","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.clim.2025.110610_bb0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.clim.2025.110610_bb0015","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/art.39771","article-title":"Elevated IgA Plasmablast levels in subjects at risk of developing rheumatoid arthritis","volume":"68","author":"Kinslow","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2025.110610_bb0020","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","article-title":"Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis","volume":"65","author":"Brink","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2025.110610_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.clim.2025.110610_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/kes371","article-title":"Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns","volume":"52","author":"van de Stadt","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.clim.2025.110610_bb0035","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/annrheumdis-2012-202868","article-title":"The fibrin-derived citrullinated peptide beta60-74Cit(6)(0),(7)(2),(7)(4) bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies","volume":"73","author":"Cornillet","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.clim.2025.110610_bb0040","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.40098","article-title":"Brief report: anti-carbamylated protein antibodies in rheumatoid arthritis patients are reactive with specific epitopes of the human fibrinogen beta-chain","volume":"69","author":"Jones","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.clim.2025.110610_bb0045","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.174.8.5057","article-title":"Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides","volume":"174","author":"Chapuy-Regaud","year":"2005","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2025.110610_bb0050","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2025.110610_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001278","article-title":"Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis","volume":"6","author":"Joshua","year":"2020","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.clim.2025.110610_bb0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.semarthrit.2016.09.011","article-title":"Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-a longitudinal analysis","volume":"46","author":"Wunderlich","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2025.110610_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000564","article-title":"Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study","volume":"4","author":"Jansen","year":"2018","journal-title":"RMD Open"},{"key":"10.1016\/j.clim.2025.110610_bb0070","first-page":"79","author":"Maldonado","year":"2024"},{"issue":"2","key":"10.1016\/j.clim.2025.110610_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40744-021-00404-x","article-title":"Differential changes in ACPA fine specificity and gene expression in a randomized trial of abatacept and adalimumab in rheumatoid arthritis","volume":"9","author":"Jabado","year":"2022","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.clim.2025.110610_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733511","article-title":"Anti-carbamylated fibrinogen antibodies might be associated with a specific rheumatoid phenotype and include a subset recognizing in vivo epitopes of its gamma chain one of which is not cross reactive with anti-citrullinated protein antibodies","volume":"12","author":"Brevet","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2025.110610_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","article-title":"The influence of ACPA status and characteristics on the course of RA","volume":"8","author":"Willemze","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.clim.2025.110610_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004746","article-title":"Immune reactivity directed against the carbamylated fibrinogen alpha chain does not cross-react with citrullinated fibrinogen immunodominant peptides in patients with rheumatoid arthritis","volume":"10","author":"Brevet","year":"2024","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.clim.2025.110610_bb0095","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/annrheumdis-2019-216499","article-title":"Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications","volume":"79","author":"Kissel","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2025.110610_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2025.105869","article-title":"Could the anti-modified protein antibody concept help better define seronegative rheumatoid arthritis?","author":"Brevet","year":"2025","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.clim.2025.110610_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cei.13206","article-title":"Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis","volume":"194","author":"Kastbom","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2025.110610_bb0110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/annrheumdis-2015-207942","article-title":"Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial","volume":"75","author":"Sokolove","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2025.110610_bb0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2016-209297","article-title":"Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs","volume":"76","author":"Figueiredo","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2025.110610_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-018-1520-4","article-title":"Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes","volume":"20","author":"de Moel","year":"2018","journal-title":"Arthritis Res. Ther."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:21:07Z","timestamp":1764318067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625001858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["S1521661625001858"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110610","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110610"}}